Clinical characteristics of fast and slow progressors of infarct growth in anterior circulation large vessel occlusion stroke. Issue 7 (July 2021)

• Record Type: Journal Article
• Authors: Rocha, Marcelo; Desai, Shashvat; Son, Jiyeon; Tonetti, Daniel A; Jovin, Tudor; Jadhav, Ashutosh P
• Is Part Of: Journal of cerebral blood flow & metabolism. Volume 41:Issue 7(2021)
• Page Start: 1517
• Page End: 1522
• Publication Date: 2021-07
• Subjects: Stroke -- anterior cerebral circulation infarction -- reperfusion -- patient selection -- predictors; Cerebral circulation -- Periodicals; Brain -- Metabolism -- Periodicals; Brain -- Blood-vessels -- Periodicals; Cerebrovascular disease -- Periodicals; 612.824
• DOI: 10.1177/0271678X211015068
• Languages: English
• ISSNs: 0271-678X

Abstract

Fast and slow progressor phenotypes of infarct growth due to anterior circulation large vessel occlusion (ACLVO) remain poorly understood. We aimed to define clinical predictors of fast and slow progressors in a retrospective study of patients with ACLVO who underwent baseline advanced imaging within 24 hours of stroke onset. Fast progressors (ischemic core > 70 ml, < 6 hours after onset) and slow progressors (ischemic core ≤ 30 ml, 6 to 24 hours after onset) were identified amongst 185 patients. Clinical and laboratory variables were tested for association with fast or slow progressor status. In the early epoch, no significant differences were found between fast progressors and controls. In the delayed epoch, slow progressors had a median NIHSS of 14 versus 20 (p < 0.01) and MCA occlusion in 80% versus 63% (p < 0.05) relative to controls. In multivariate analyses, NIHSS (OR 0.83, 95% CI 0.73-0.95), hyperlipidemia (OR 4.24, 95% CI 1.01 – 19.3) and hemoglobin concentration (OR 0.75, 95% CI 0.57 – 0.99) were independently associated with slow progressor status. This study indicates that lower initial stroke symptom severity, a history of hyperlipidemia and mild anemia are associated with individual tolerance to ACLVO stroke.